Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
A game changing solution for the pharmaceutical industry
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
Lack of technology transfer stands out as a formidable barrier
Subscribe To Our Newsletter & Stay Updated